Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 2
2015 3
2016 2
2021 3
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Boosting ethics review capacity in public health emergency situations: Co-creation of a training model for French-speaking research ethics committees.
Maketa V, Luzolo F, Muhindo Mavoko H, Claeys Y, Munday F, Yemesi Benge R, Bongo Pasi W, Mankindu D, Mampunza S, Lukanu P, Kasongo M, Ntabe Namegabe E, Kambale Karafuli L, Phanzu Mavinga D, Milandu Massamba E, Muaka Khoso CA, Ravinetto R. Maketa V, et al. Trop Med Int Health. 2022 Oct;27(10):934-940. doi: 10.1111/tmi.13815. Epub 2022 Sep 5. Trop Med Int Health. 2022. PMID: 36053926 Free PMC article. Review.
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Zola Matuvanga T, Larivière Y, Lemey G, De Bie J, Milolo S, Meta R, Esanga E, Vermeiren PP, Thys S, Van Geertruyden JP, Van Damme P, Maketa V, Matangila J, Mitashi P, Muhindo-Mavoko H. Zola Matuvanga T, et al. Among authors: maketa v. Vaccine. 2022 May 31;40(25):3470-3480. doi: 10.1016/j.vaccine.2022.04.094. Epub 2022 May 9. Vaccine. 2022. PMID: 35550847 Free article.
Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
Zola Matuvanga T, Mariën J, Larivière Y, Osang'ir BI, Milolo S, Meta R, Esanga E, Maketa V, Matangila J, Mitashi P, Ahuka Mundeke S, Muhindo-Mavoko H, Muyembe Tamfum JJ, Van Damme P, Van Geertruyden JP. Zola Matuvanga T, et al. Among authors: maketa v. PLoS One. 2023 Sep 1;18(9):e0286479. doi: 10.1371/journal.pone.0286479. eCollection 2023. PLoS One. 2023. PMID: 37656725 Free PMC article.
Phase 3 Evaluation of an Innovative Simple Molecular Test for the Diagnosis of Malaria and Follow-Up of Treatment Efficacy in Pregnant Women in Sub-Saharan Africa (Preg-Diagmal).
Kiemde F, van Dijk N, Tinto H, Muhindo-Mavoko H, Valia D, Kaboré B, Kabalu J, Maketa V, Mens P, Schallig H. Kiemde F, et al. Among authors: maketa v. Trop Med Infect Dis. 2022 Sep 1;7(9):219. doi: 10.3390/tropicalmed7090219. Trop Med Infect Dis. 2022. PMID: 36136630 Free PMC article.
Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate-PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREG.
Maketa V, Kabalu J, Kabena M, Luzolo F, Muhindo-Mavoko H, Schallig HDFH, Kayentao K, Mens PF, Lutumba P, Tinto H. Maketa V, et al. Trials. 2022 Nov 28;23(1):963. doi: 10.1186/s13063-022-06884-8. Trials. 2022. PMID: 36443882 Free PMC article. Clinical Trial.
Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
Larivière Y, Zola T, Stoppie E, Maketa V, Matangila J, Mitashi P, De Bie J, Muhindo-Mavoko H, Van Geertruyden JP, Van Damme P. Larivière Y, et al. Among authors: maketa v. BMJ Open. 2021 Sep 28;11(9):e046835. doi: 10.1136/bmjopen-2020-046835. BMJ Open. 2021. PMID: 34588237 Free PMC article.
Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
Larivière Y, Garcia-Fogeda I, Zola Matuvanga T, Isekah Osang'ir B, Milolo S, Meta R, Kimbulu P, Robinson C, Katwere M, McLean C, Hens N, Matangila J, Maketa V, Mitashi P, Muhindo-Mavoko H, Van Geertruyden JP, Van Damme P. Larivière Y, et al. Among authors: maketa v. J Infect Dis. 2023 Aug 24:jiad350. doi: 10.1093/infdis/jiad350. Online ahead of print. J Infect Dis. 2023. PMID: 37673423
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study.
Zola Matuvanga T, Johnson G, Larivière Y, Esanga Longomo E, Matangila J, Maketa V, Lapika B, Mitashi P, Mc Kenna P, De Bie J, Van Geertruyden JP, Van Damme P, Muhindo Mavoko H. Zola Matuvanga T, et al. Among authors: maketa v. J Med Internet Res. 2021 Aug 9;23(8):e28573. doi: 10.2196/28573. J Med Internet Res. 2021. PMID: 34378545 Free PMC article. Clinical Trial.
21 results